Quick answer
1 insider bought Grace Therapeutics, Inc. (GRCE) stock on the open market between 2026-10-08 and 2026-10-12, totalling $59,366; the largest buyer was Opaleye Management Inc. (10% owner) with $59,366, per SEC Form 4 filings.
Insider buyers
| Buyer | Role | Total bought |
|---|---|---|
| Opaleye Management Inc. | 10% owner | $59,366 |
SEC sources
Updated 2026-10-13. Source: SEC EDGAR filings (linked above). Data only. Not investment advice, no buy/sell recommendation.
Related answers
- GRCE insider buying this week: $59,366 in open-market buys
- GRCE earnings dates: last reported 2026-08-13 (Grace Therapeutics, Inc.)